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ABSTRACT
Malaria parasites have a complex life cycle, during
which they undergo significant biological changes
to adapt to different hosts and changing environ-
ments. Plasmodium falciparum, the species respon-
sible for the deadliest form of human malaria,
maintains this complex life cycle with a relatively
small number of genes. Alternative splicing (AS)
is an important post-transcriptional mechanisms
that enables eukaryotic organisms to expand their
protein repertoire out of relatively small number
of genes. SR proteins are major regulators of AS in
higher eukaryotes. Nevertheless, the regulation
of splicing as well as the AS machinery in
Plasmodium spp. are still elusive. Here, we show
that PfSR1, a putative P. falciparum SR protein,
can mediate RNA splicing in vitro. In addition, we
show that PfSR1 functions as an AS factor in
mini-gene in vivo systems similar to the mammalian
SR protein SRSF1. Expression of PfSR1-myc in
P. falciparum shows distinct patterns of cellular
localization during intra erythrocytic development.
Furthermore, we determine that the predicted
RS domain of PfSR1 is essential for its localization
to the nucleus. Finally, we demonstrate that
proper regulation of pfsr1 is required for parasite
proliferation in human RBCs and over-expression
of pfsr1 influences AS activity of P. falciparum
genes in vivo.
INTRODUCTION
Plasmodium falciparum is the causative agent of the
deadliest form of human malaria infecting millions each
year, resulting in over million deaths primarily of children
and pregnant women (1). The malaria parasite has a
complex life cycle, during which it undergoes significant
morphological changes to be able to adapt to different
hosts and changing environments. These parasites alter-
nate between the mosquito and human hosts. Within each
host they have extracellular motile forms that evolved
specific molecular machinery to invade and propagate
within either the mid-gut epithelial cells in the mosquito
or hepatocytes and red blood cells (RBCs) in the human
host. These changes are mediated by tight regulation of
cell cycle-dependent gene-expression patterns (2). Thus,
the complexity of P. falciparum biology is achieved
with a rather small genome that contains 5700 genes
(3) (http://plasmodb.org/plasmo/showXmlDataContent
.do?name=XmlQuestions.GeneMetrics). It is striking
that P. falciparum adapted to this complex life cycle
with less number of genes than the yeast Saccharomyces
cerevisiae, an organism that has a much simpler life cycle
(http://www.yeastgenome.org/cache/genomeSnapshot.html).
One way by which eukaryotic organisms can regulate
gene expression and expand their protein repertoire
out of a limited number of genes is through post-
transcriptional regulation of alternative splicing (AS) of
pre-mRNA that enable synthesis of functionally different
protein isoforms from the same pre-mRNA transcripts.
In mammals, it is estimated that >90% of genes undergo
AS (4).
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In recent years there have been an increasing number of
studies reporting on different AS events in transcripts
from numerous Plasmodium genes. To our knowledge,
the first report of AS in plasmodium was of the blood
stage antigen 41-3 precursor (PFL0385c) in P. falciparum
(5). In addition, multiple spliced variants were found to
encode for different functional isoforms of P. falciparum
adenylyl cyclase, including a novel isoform that is
expressed in sexual stages (6). AS also plays a key role
in developmental regulation of different isoforms
encoded by the maebl gene implicated in red cell
invasion in several plasmodium species, demonstrating a
high degree of conservation of AS mechanisms across
Plasmodium evolution (7). Interestingly, distinct spliced
variants were reported in the 50-UTRs of transcripts
from the yir multi-copy gene family, a large complement
of genes implicated in antigenic variation in P. yoelii (8).
Additional AS events have been reported in a small-scale
analysis of cDNA libraries (9). Recently genome wide
studies using RNA-seq of different stages during the
intra erythrocytic development cycle (IDC) implied
that over 300 AS events occur in 4% of the genes in
the malaria genome (10,11). This evidence suggests that
post-transcriptional regulation of gene expression through
AS of pre-mRNAs is an important mechanism by which
Plasmodium parasites regulate gene expression and
expand their proteome diversity. However, despite the
fact that 54% of the parasite’s genes contain introns
(3) and that 30% of the genes contain at least two
introns (Supplementary Figure S1), very little is known
about splicing factors in Plasmodium and even less is
known about mechanisms that regulate gene expression
through AS.
The best characterized AS factors in eukaryotes
belong to the family of SR proteins (12–14). These
proteins have a modular structure consisting of a
C-terminus SR domain as well as one or two RNA recog-
nition motifs (RRMs). SR proteins function as a part of
the spliceosome and are required for both constitutive and
alternative splicing (15). SR proteins are functionally
regulated through specific phosphorylation of their RS
domain by several kinases, particularly by SR
protein-specific kinases belonging to the SRPK family
(13). The complex regulation of AS is only partly under-
stood in higher eukaryotes and remains elusive in lower
eukaryotes. Nevertheless, the involvement of SR proteins
with AS activity was reported in Schizosaccharomyces
pombe (16) and Trypanosoma cruzi (17). A recent study
demonstrated that P. falciparum has a functional SRPK
homolog (PfSRPK1), which is involved in mRNA splicing
in this parasite (18). This elegant study also showed that
PfSRPK1 is associated with a putative splicing factor can-
didate named PfSR1. PfSRPK1 could phosphorylate
PfSR1 and thus affect its binding affinity to mRNA
in vitro, implying that these two proteins are potentially
regulatory components of the P. falciparum splicing
machinery.
Using recombinant purified PfSR1 protein, we demon-
strate that it is a functional SR protein that can comple-
ment splicing reactions in vitro, thus identifying the first
validated splicing factor in P. falciparum. In addition,
we show that PfSR1 regulates AS activity in mini-gene
systems in mammalian cells similar to the human
splicing factor SRSF1 (previously known as SF2/ASF)
(19) indicating that it can also function as an AS factor.
Using parasites transfected with PfSR1-myc, we
determined its cellular localization during the IDC and
by mutation analyses, we identified the RS domain as its
nuclear localization signal (NLS). Finally, we show that
proper regulation of the pfsr1 gene is essential for
P. falciparum development in human RBCs.
MATERIALS AND METHODS
Bioinformatics search for putative SR proteins
In order to find putative SR proteins in P. falciparum, we
initially performed BLAST searches against all predicted
proteins from P. falciparum using a consensus RS domain
sequence consisting of 30 tandem Ser/Arg dipeptides
repeats as a query. This enabled us to identify sequences
that are compositionally biased in alternating Ser/Arg
residues as described (20). Further searches for protein
motifs such as the SR domain of SRSF1 or dipeptide
patterns such as RSRS or SRSR were performed against
all predicted proteins in P. falciparum using the PlasmoDB
(http://plasmodb.org/plasmo/). Candidate genes were
further analyzed using Myhits (SIB) (http://myhits.isb-
sib.ch/) in order to identify the genes that contain a pre-
dicted RRM as well as a putative RS domain. Multiple
sequence alignments of the putative SR and SR-like
proteins were performed with the MUSCLE program
(21). Phylogenetic tree was built with Neighbor-Joining
algorithm (22) and the evolutionary distances among can-
didate SR proteins were calculated using the Poisson cor-
rection method with MEGA5 software (23). Evolutionary
distances are essentially the number of amino acids sub-
stitutions per aligned site.
Cell cultures
All parasites used were derivatives of the NF54 parasite
line and were cultivated at 5% hematocrit in RPMI 1640
medium, 0.5% Albumax II (Invitrogen), 0.25% sodium
bicarbonate and 0.1mg/ml gentamicin. Parasites were
incubated at 37C in an atmosphere of 5% oxygen, 5%
carbon dioxide and 90% nitrogen. Parasite cultures were
synchronized using percoll/sorbitol gradient centrifuga-
tion as previously described (24,25). Briefly, infected
RBCs were layered on a step gradient of 40/70% percoll
containing 6% sorbitol. The gradients were then
centrifuged at 12 000g for 20min at room temperature.
Highly synchronized, late stage parasites were recovered
from the 40/70% interphase, washed twice with complete
culture media and placed back in culture. The level of
parasitemia was calculated for each time point by
counting three independent blood smears stained with
Giemsa under light microscope.
HEK 293T cells were grown in Dulbecco’s modified
Eagle’s medium (Biological Industries Inc., Israel) supple-
mented with 10% fetal bovine serum (FCS), penicillin and
streptomycin at 37C with 5% CO2.
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Plasmid construction
In order to express PfSR1 in the mammalian cells a
synthetic cDNA of pfsr1 with codons optimized for
mammalian cells was synthesized by GeneArt, fused
to a T7 tag. The synthetic pfsr1 was amplified
using PfSR1PTTF-XbaI–PfSR1PTT-HisR primers (see
Supplementary Materials) and cloned into the pTT3
plasmid (26) using XbaI and BamHI restriction sites,
creating His-tagged PfSR1 similar to the His-tagged
SRSF1 previously described (27).
The synthetic pfsr1 fused to a T7 tag was cloned into
pcDNA3 plasmid (Invitrogen) using XhoI and KpnI re-
striction sites creating a similar plasmid to the
pCDNA3-SRSF1 previously described (27).
PfSR1 was cloned into the expression vector pHBIRH
(28) previously described and fused to a myc epitope tag to
generate pHBISR1myc. The myc tag was amplified using
the primers mycF–mycR (see Supplementary Materials)
and cloned using SpeI and SacI restriction sites. pfsr1
was amplified using the primers PfSR1F–PfSR1R (see
Supplementary Materials) and cloned into the pHBIRH
plasmid using SalI and SpeI restriction sites.
To express PfSR1DRRM1myc the pfsr1 gene was
amplified using the primers dRRM1F–PfSR1R
(see Supplementary Materials) and cloned into the
pHBIRH plasmid using SalI and SpeI restriction sites.
Similarly, PfSR1DRSmyc was created using the primers
PfSR1F–dRSR (see Supplementary Materials). PfSR1D
RRM2myc was created using quick-change mutagenesis
with the dRRM2F–dRRM2R primers (see Supplementary
Materials) and using pHBIPfSR1myc as template for poly-
merase chain reaction (PCR) amplification.
Mammalian cell transfections
HEK 293T cells were transfected using Fugene 6 (Roche
Diagnostics), according to the manufacturer’s recommenda-
tions. In order to purify the PfSR1-His protein, cells were
transfected using linear polyethylenimine (PEI 25000;
Polysciences Inc.). A transfection mix consisting of 1mg
plasmid DNA, 2mg PEI and 50ml of JMEM was prepared
for every 1ml of cell culture to be transfected. The mix was
incubated at room temperature for 10–15min and was then
added to the cell culture. Forty-eight hours post-transfection
cells were collected and analyzed.
Parasite transfections
Parasites were transfected as previously described (29).
Briefly, 0.2 cm electroporation cuvettes were loaded with
0.175ml of erythrocytes and 100 mg of plasmid DNA in
incomplete cytomix solution. Stable transfectants were ini-
tially selected on 2 mg/ml blasticidin-S-hydrochloride
(Invitrogen, USA). In order to obtain parasites carrying
high plasmid copy numbers, these cultures were then sub-
jected to 6 mg/ml blasticidin.
Genomic DNA extraction, RNA extraction and cDNA
synthesis
Genomic DNA was extracted as described (30). Briefly,
iRBCs were pelleted and lysed with Saponin. RBC-free
parasites from 20ml cultures were then pelleted, washed
with phosphate buffered saline (PBS), and taken up
in 200ml TSE buffer (100mM NaCl, 50mM EDTA,
20mM Tris, pH 8), 40 ml of 10% sodium dodecyl sulfate
(SDS) and 20 ml 6M NaClO4. This suspension was
rocked for 12 h and genomic DNA was extracted with
phenol/chloroform. The resulting DNA was taken up in
100 ml dH2O.
RNA extraction and cDNA synthesis were performed
as described (31). Briefly, RNA was extracted from
synchronized parasite cultures at 36 h post-invasion.
RNA was extracted with the TRIZOL LS Reagent as
described (32) and purified on PureLink column
(Invitrogen) according to manufacturer’s protocol.
Isolated RNA was then treated with recombinant
Deoxyribonuclease I (Takara) to degrade contaminating
gDNA. cDNA synthesis was performed from 750 ng total
RNA with Primescript RT reagent (Takara) with oligo
dT (Takara) as described by the manufacturer.
Real-time reverse transcriptase–qPCR
Transcript copy numbers were determined using the
formula 2CT as described in the Applied Biosystems
User Bulletin 2 using NF54 gDNA as the calibrator.
Specifically, relative copy number was calculated as two
exponential negative ((Ct target gene in cDNACt refer-
ence gene in cDNA) (Ct target gene in gDNA–Ct target
gene in gDNA)). Relative copy numbers of pfsr1 and
renilla luciferase were calculated comparing to the expres-
sion of the housekeeping gene arginyl–tRNA synthetase
(PFL0900c). All reverse transcriptase (RT)–qPCR assays
were performed at least in duplicate for each template with
no apparent differences, and each experiment was
completed three times in its entirety, again with no signifi-
cant differences.
The housekeeping and other control primers used for
RT–qPCR were previously published (renilla in (28) and
arginyl–tRNA synthetase in (31)). Ectopic expression of
pfsr1 was measured using primers designated to specific-
ally amplify the fusion of pfsr1 and the myc tag (see
Supplementary Materials).
Protein purification
293T cells were transfected with human pTT3-SRSF1-His
or pTT3-PfSR1-His and harvested 48 h after transfection.
Cells were re-suspended in lysis buffer (50mM Tris–HCl
[pH 8.0], 1M NaCl, 10mM imidazole, 20mM
b-mercaptoethanol and 0.1% [vol/vol] Triton X-100)
and centrifuged after sonication to remove insoluble
material. Most cellular proteins were precipitated by
using ammonium sulfate at 40% saturation at 4C and
were separated by centrifugation. His-tagged proteins
were purified from the supernatant by nickel–agarose
affinity chromatography.
In-vitro splicing assay
In vitro splicing assays were done as described previously
(33,34). Briefly, radiolabeled Ftz reporter pre-mRNAs
was prepared by the in vitro transcription of plasmids by
SP6 RNA polymerase, in the presence of [a-32P]UTP.
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Pre-mRNAs were incubated under splicing conditions
in HeLa cells nuclear or cytoplasmic S100 extracts, as
described previously. RNAs were extracted and analyzed
by denaturing polyacrylamide gel electrophoresis (PAGE)
and phosphorimager analysis on a Fujifilm FLA-5100
instrument (Fuji Medical Systems Inc., USA).
Immuno-fluorescence assay
Immuno-fluorescence assays (IFA) were performed as
described (http://www.mr4.org/Portals/3/Pdfs/Protocol
Book/Methods_in_malaria_research.pdf) with slightly
modifications. Briefly, RBCs were lysed, washed twice in
PBS and fixed in 4% paraformaldehyde, followed by
three washes in PBS. Parasites were blocked using 2%
bovine serum albumin (BSA) in PBS+0.1% tween20
(PBST). Mouse-anti-myc (Santa-Cruz) antibodies were
incubated at 1:1000 dilution in blocking solution,
washed three times in PBST and incubated with 1:250
dilution of 488-conjugated rabbit anti-mouse anitbodies
(Invitrogen). After final washes, slides were sealed with
ProLong Gold Reagent (Invitrogen).
Western blot analysis
In order to collect proteins from the 293T cells, trans-
fected cells were washed twice with PBS and collected in
sample buffer (63mM Tris–HCl, 10% glycerol, 2% SDS
and 0.0025% Bromophenol Blue). To collect parasite
proteins, iRBCs were lysed in saponin, parasites were
washed twice in PBS and collected in sample buffer.
Proteins were subjected to SDS–PAGE (10% polyacryl-
amide) and electroblotted to nitrocellulose membrane.
Immunodetection was carried out using mouse-anti-
myc antibody (Santa-Cruz) or mouse-anti-T7 antibody
(Novagen; 1:5000), followed by rabbit anti-mouse
antibody conjugated to Horseradish Peroxidase (HRP)
(Jackson, ImmunnoResearch Laboratories, Inc.) and de-
veloped in EZ/ECL solution (Israel Biological Industries
Ltd).
RESULTS
PfSR1 is a functional SR protein that can mediate
pre-mRNA splicing
Very little is known about splicing factors in Plasmodium
spp., however, it is clear that the splicing machinery as
well as the factors involved in regulation of AS functions
in these pathogens. We used BLAST search in the
Plasmodium genome database http://plasmodb.org/
plasmo/ to look for candidate genes in P. falciparum
that encode potential SR proteins (Figure 1A). We
found that P. falciparum may have more SR proteins
than were previously identified (9,11,18,35).
Nevertheless, to our knowledge their involvement in
RNA metabolism had not been demonstrated. As a first
step to investigate whether P. falciparum has functional
SR proteins, we chose to begin our analysis with PfSR1,
a protein that shares the highest sequence homology to the
mammalian SR protein SRSF1 (SF2/ASF) (Figure 1B).
PfSR1 was recently shown to be phosphorylated by
PfSRPK1 at its predicted SR domain, and its ability
to bind RNA in vitro was also demonstrated (18). We
compared the first RRM domain of PfSR1 and the
human SRSF1 (PDB ID 1x4a), using homology
modeling. Overall the RRMs are highly conserved with
51% sequence identity over a total length of 80 amino
acids (Figure 1C). To test whether PfSR1 has the same
splicing activity as metazoan SR proteins that can
complement an in vitro splicing reaction, we purified a
recombinant version of PfSR1 fused to a 6 His-tag
(Figure 2A). We then applied an in vitro S100 complemen-
tation assay to determine whether the recombinant PfSR1
by itself can restore the splicing of pre-mRNA in splicing
deficient S100 extract. The S100 extracts lack SR proteins
and this assay has been previously used to characterize
several recombinant mammalian SR proteins including
SRSF1 that could complement splicing when added to
this extract (33,34). We therefore compared the comple-
mentation activity of PfSR1 with the mammalian SRSF1
as a positive control. Incubation of increasing concentra-
tions of recombinant PfSR1 to the S100 incomplete
extracts was sufficient to complement splicing of the Ftz
reporter pre-mRNA similar to the recombinant SRSF1
(Figure 2B, Lane 3 compared with Lanes 7 and 8).
The appearance of splicing products was correlated with
the increasing concentration of the recombinant PfSR1,
similar to the effect observed with the recombinant
SRSF1 (Figure 2B, Lanes 5 and 6). Similar results
were obtained with the b-globin reporter pre-mRNA
(Supplementary Figure S2). We concluded that PfSR1
by itself could mediate splicing of pre-mRNA and demon-
strate that PfSR1 is a functional splicing factor.
PfSR1 is an AS factor with similar activity to SRSF1
The fact that PfSR1 by itself could complement splicing
of pre-mRNA in an in vitro S100 complementation
assay encouraged us to further investigate whether
PfSR1 can also function as AS factor in living cells.
Toward this aim we applied two mini-gene constructs
(E1A and b-globin duplicated 50-splice sites [D50-ss]) suc-
cessfully used to demonstrate the AS activity of the mam-
malian SRSF1 (19,27,36). In these systems, HEK 293T
cells are cotransfected with an expression vector that
over-expresses a candidate AS factor together with
another vector that carries an artificial mini-gene. The
E1A mini-gene contains several competing 50-ss and
could potentially give rise to a few different alternative
spliced mRNA products (19). Following transfection,
the cotransfected cells are harvested for further analyses
of protein expression and detection of differential AS
isoforms of pre-mRNA of the mini-gene (Figure 3A).
Our initial attempts to express PfSR1 in the HEK 293T
cells had very poor protein yield (data not shown). We
reasoned that since the P. falciparum genome is AT rich,
its codon usage might not be optimal for protein transla-
tion in mammalian cells. Therefore, we synthesized PfSR1
with a codon bias that was predicted to be optimal for
expression in these mammalian cells (Supplementary
Figure S3). The synthetic pfsr1 gene was cloned into the
pcDNA3 expression vector fused to a T7 epitope tag
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Gene name and 
annotation in Length 
A
Sorber et  
al. 2011
Tra2B246   PF10_0028
RNA binding, putative
Dixit et al., 
2010
SRSF1
(SF2/ASF)
298PFE0865c
Pre-mRNA splicing 
factor, (SR1)
Sorber et  
al. 2011
SRSF12308PFE0160c
Ser/Arg rich splicing 
factor, putative
309PFC0865w
Ref.HomologyPutative Protein domainsPlasmoDB (aa)
RNA binding, putative
527PF13_0147 
RNA binding, putative
Sorber et  
al. 2011
SFRS4538PF10_0217
Pre-mRNA splicing 
factor, putative
Sorber et  
al. 2011
U2 snRNP833PF14_0656
U2 snRNP auxiliary 
factor, putative
864MAL13P1.120
Splicing factor, 
putative
1125PF07_0066
RNA binding, putative
1483PF11_0111
Asparagine rich 
antigen
Agarwal et al 
2011
SRSF1
(SF2/ASF)
200PF11_0205
alternative splicing  
factor ASF-1, putative
RRM RS
B C
Figure 1. Putative SR and SR-like proteins in P. falciparum. (A) Schematic representation of the domain structure of P. falciparum putative proteins
that are predicted to contain RNA Recognition Motif (RRM, ellipses) and SR domain (RS, rectangles). Pervious predictions of homologs are shown
with references (B) A phylogenetic tree built with the Neighbor-Joining algorithm based on the entire amino acid sequence of the predicted
P. falciparum SR proteins. As shown the closest homologs of SRSF1 are PfSR1 (PFE0865c) and PF10_0217, respectively. (C) Homology
modeling of the first RRM of PfSR1 based on the human SRSF1 RRM1. The crystal structure of the human SRSF1 was retrieved from the
Protein Data Bank (http://www.rcsb.org/pdb/home/home.do, PDB-1x4aA). The two RRMs have 51% identity over 80 amino acids. The Z-score for
the model quality calculated using ProSA (https://prosa.services.came.sbg.ac.at/prosa.php) is 5.5.
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(Figure 3A) and was found be well expressed in the
HEK 293T cells (Figure 3B). To determine whether
PfSR1 can influence the choice of different 50-ss and
thus give rise to alternatively spliced isoforms we ex-
pressed PfSR1 in the presence of either the E1A or the
b-globin mini-genes and found that for both mini-gene
constructs PfSR1 acts as AS factor. In cells that were
cotransfected with the adenovirus E1A mini-gene and an
empty pcDNA3 vector, the putative AS machinery gave
rise to three differentially spliced isoforms of E1A that are
detected by RT–PCR. Remarkably, in cells in which either
PfSR1 or SRSF1 are coexpressed with the mini-gene,
there is a clear change in the ratio of the different
mRNA isoforms compared with the cells that were trans-
fected with the empty pcDNA3 vector. In both PfSR1
and SRSF1 over-expressing cells there is an increase
in the amount of the distal and proximal isoforms
S13 and S9 (600 and 150 bp, respectively) while the
amount of the intermediate isoform S12 (450 bp) decreases
(Figure 3C and D). These results show that ectopic expres-
sion PfSR1 promotes the proximal 50-ss selection and
modulate the AS regulation of the E1A mini-gene
similar to SRSF1. Similarly, when PfSR1 is expressed
in the presence of the b-globin D50-ss mini-gene (27,36)
the balance between the distal and proximal 50-ss selection
is affected, indicating that PfSR1 strongly promotes
the proximal 50-ss. In cells that were transfected with
the empty pcDNA3 vector the dominant spliced
mRNA product is the 586-bp isoform that corresponds
with splicing at the distal ss. However, in cells in
which PfSR1 is expressed the 810-bp isoform, which cor-
responds with the proximal ss, becomes significantly
more abundant than in the cells containing the empty
pcDNA3 vector (Figure 3E and F). This splicing pat-
tern is similar to the results obtained in the SRSF1
expressing cells. Altogether, these results demonstrate
that PfSR1 regulate ss selection resulting in AS patterns
which are similar to those that are obtained with SRSF1
BA
SR cDNA His
+− +
− + +− −− −
− + + + +
−
SRSF1 PfSR1
NE
S100
SRSF1 PfSR1
1 2 4 1 2 4µl
C
1 2 3 4 5 6 7 8
Figure 2. PfSR1 is a functional SR protein that can mediate pre-mRNA splicing. Recombinant PfSR1 can complement S100 extracts and rescue the
splicing activity similar to SRSF1. (A) Schematic of the expression vector used to express the recombinant PfSR1 and SRSF1 in 293T cells. cDNA of
both genes was cloned into the expression vector fused to a His-tag. (B) SDS–PAGE presenting the purified SRSF1 and PfSR1 loaded on gel in
increasing volumes (1, 2 and 4 ml, respectively). (C) Complementation of splicing activity of PfSR1 and SRSF1 in S100 extracts (in vitro splicing
assay). Increasing amounts of purified SRSF1 or PfSR1 were added to S100 extracts in the presence of radiolabeled Ftz reporter pre-mRNA. Lane 1:
labeled Ftz pre-mRNA only; Lane 2: nuclear extract (NE)+Ftz; Lane 3: S100 extract+Ftz; Lane 4: NE+S100+Ftz; Lanes 5–6: S100+Ftz with
increasing amounts of SRSF1; Lanes 7 and 8: S100+Ftz with increasing amounts of PfSR1. Schematics of pre-mRNA, spliced mRNA and the
spliced intron are shown in the left.
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α T7
A B mini-gene SR expression vector 
T7    SR 
37 KDa -
proteinRNA
13S
12S
C D 
GAPDH
9S
E 
F Pre-mRNA
mRNA proximal 5’ ss
mRNA distal 5’ ss
GAPDH
Figure 3. PfSR1 is an AS factor with similar activity to SRSF1. (A) Schematic illustration of the experimental procedure designed to demonstrate
AS activity of PfSR1. HEK 293T cells were cotransfected with plasmids that carried a mini-gene as well as an expression vector (pcDNA3).
Forty-eight hours post-transfection the cells were harvested and their RNA and protein content were analyzed. (B) Western blot analysis using
anti-T7 antibody showing the expression of the tagged SRSF1 (Lane 2) and PfSR1 (Lane 3). An empty pcDNA3 vector was used as a negative
control (Lane 1). (C) RT–PCR amplification of total RNA extracted from HEK 293T cells that were cotransfected with the E1A mini-gene obtained
differential splicing patterns mediated by PfSR1 and SRSF1 compared with the control. Schematic of the mini-gene and the differentially spliced
isoforms is shown on the left. GAPDH was used as loading control and is presented in the lower panel. (D) Quantification of the changes in the
proportion of each spliced isoform of E1A obtained after transfection with PfSR1 and SRSF1 compared with the control. The density of each band
is presented as a proportion of the total signal obtained. The averages and standard errors of three different experiments are presented. (E) RT–PCR
amplification of total RNA extracted from 293T cells that were cotransfected with the b-globin mini-gene obtained differential splicing patterns
mediated by PfSR1 and SRSF1 compared with the control. Schematic of the mini-gene and the differentially spliced isoforms is shown on the left.
GAPDH was used as loading control and is presented in the lower panel. (F) Quantification of the changes in the proportion of each spliced isoform
of b-globin obtained after transfection with PfSR1 and SRSF1 compared with the control. The density of each band is presented as a proportion of
the total signal obtained. The averages and standard errors of two different experiments are presented.
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and thus indicate that PfSR1 functions as a bona fide
SR protein.
Analyses of the dynamic cellular localization of
PfSR1 during IDC indicates that its RS domain function
as NLS
In higher eukaryotes it was shown that several SR protein
shuttle between the cytoplasm and the nucleus and that
specific protein domains are important for proper cellular
localization (37,38). It was recently shown that the
dynamic cellular localization of PfSR1 during the IDC
correlates with the localization of PfSRPK1 (18).
Therefore, we were interested to investigate whether the
RRM domains and/or the RS domain have a role in
determining the cellular localization of PfSR1. We
ectopically expressed the entire PfSR1 protein as well as
three mutants in which either RRM1, RRM2 or the RS
domains had been deleted. These mutants were named
RRM1, RRM2 and RS, respectively. The entire
pfsr1 as well as the mutated genes were cloned into the
expression vector pHBISR1myc (see plasmid map in
Figure 5A) fused to a myc epitope tag that enables
specific immuno-fluorescence visualization. These con-
structs also express the bsd resistance gene that allows us
to select for parasite populations that stably carry the
episomes using drug selection with blasticidin S.
Interestingly, we found that the RS mutants (Figure
4D) had a different cellular localization than that of the en-
tire PfSR1 protein or the RRM mutants (Figure 4A–C).
In early ring stages the complete PfSR1-myc as well as
RRM mutants localizes to the nucleus in foci that are
mainly located at the nuclear periphery. This pattern
changes later during the IDC in trophozoites, schizonts
and in gametocytes, in which PfSR1-myc and all the
mutated forms of PfSR1 are detected both in the
nucleus and in the cytoplasm. It is also apparent that
the cytoplasmic location of these different isoforms is re-
stricted to regions that are outside the parasite’s food
vacuole. Remarkably though, the RS mutant proteins
are located in the cytoplasm and not in the nucleus
indicating that the RS domain is essential for nuclear tar-
geting of PfSR1 (Figure 4D). Altogether these results
indicate that the cellular location of PfSR1 in the
parasite is dynamic during IDC and that nuclear localiza-
tion of PfSR1 is determined by the RS domain.
Proper expression of the pfsr1 gene is essential
for proliferation of blood stages parasites
In mammals, it was possible to over-express SRSF1 only
by 2-fold before the over-expressed cells underwent
apoptosis (39). Interestingly, in our IF assays on parasites
that were transfected with the pHBISR1myc constructs, we
were able to detect fluorescent signal only from a portion
of the parasite population while many parasites were not
stained. This suggests that episomal expression of PfSR1 is
not obtained from the entire parasite population. This as-
sumption was also supported by the fact that the detection
of PfSR1-myc by western blot analysis was very inefficient
and required a large amount of parasites (Supplementary
Figure S4). These results suggest that ectopic
over-expression of the pfsr1 gene could interfere with the
proper proliferation of P. falciparum in RBCs. The plasmid
pHBISR1myc is a great transgenic tool that enables both
ectopic protein expression as well as fine tuned and a
precise over-expression in P. falciparum by forcing the
parasite to carry increasing copy numbers of the
over-expression episomes (28). Using increasing concentra-
tion of blasticidin S, we attempted to achieve fine tuned
over-expression of the pfsr1 gene. In order to eliminate the
possible effect of the drug itself, we transfected parasites
with pHBIRH plasmid as a control. pHBIRH is an iden-
tical plasmid in which renilla luciferase was cloned into the
same expression vector instead of pfsr1. Following trans-
fections, these parasites were initially selected on a low
dose of 2 mg/ml blasticidin until populations that stably
carried these expression vectors were obtained. Using
qPCR of gDNA with PfSR1-myc specific primers we
determined that <2 mg/ml blasticidin both parasite popu-
lations carried a single copy of the expression vectors and
transcribed endogenous pfsr1 at similar levels (data not
shown). Interestingly, although under this dose of drug
pressure pfsr1 and renilla luciferase are transcribed at
similar levels we observed significant growth differences
between the parasite populations (Figure 5B).
Proliferation of the parasites cultures that over-expressed
pfsr1 was slower than the population expressing renilla
luciferase (Figure 5C). We then increased blasticidin con-
centrations to 6 mg/ml in attempt to increase the levels of
ectopic over-expression of the pfsr1gene. By this increase in
drug pressure we were able to achieve 8-fold increase in
both pfsr1and renilla luciferase transcription levels (Figure
5B). However, while the renilla luciferase expressing para-
sites grew rather well under this drug pressure the parasite
population over-expressing pfsr1 proliferated grew much
slower (Figure 5D). Mutation analyses of SRSF1 pointed
toward functional differences of the RRM and RS
domains in splicing (40), translation (41) and oncogenic
activity (42). We were therefore interested to test the influ-
ence of over-expression of the different PfSR1 mutants on
parasites’ proliferation. We found that parasite
over-expressing the RRM1 mutant had normal growth
rate while the proliferation of parasites over-expressing the
RRM2 and the RS mutants was significantly slower
(Figure 5E). Altogether, these results imply that ectopic
over-expression of the pfsr1 gene had caused a distinct
growth inhibition phenotype indicating that proper regu-
lation of pfsr1 is essential for parasite proliferation in
human RBCs.
Over-expression of pfsr1 influence AS activity
in P. falciparum
In order to demonstrate that PfSR1 influences AS activity
in P. falciparum, we performed large-scale screening for
different splicing isoforms in genes in which exon skipping
event has been previously reported in blood stages para-
sites (10,11,43). We used numerous primer sets designated
to identify such events by RT–PCR and compared the
different cDNA isoforms that were amplified from para-
sites over-expressing pfsr1 (pHBISR1myc) with those
detected in wild-type NF54 parasites as well as the
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Figure 4. The RS domain localizes PfSR1 to the nucleus. IFAs showing the localization of the entire PfSR1 as well as different PfSR1 mutants
lacking either the RRM or the RS domains (RRM1, RRM2 and RS, respectively) during IDC. The different forms of PfSR1 were ectopically
express fused to a myc epitope tag and detected using anti-myc antibodies. PfSR1 (green); DAPI staining (blue); developmental stages are indicated
on the left. (A) Cellular localization of PfSR1-myc. (B) Cellular localization of the PfSR1RRM1-myc. (C) Cellular localization of the
PfSR1RRM2-myc. (D) Cellular localization of the PfSR1RS-myc. The entire PfSR1 and two RRM mutants shuttle between the nucleus
and cytoplasm, whereas the RS mutant localizes to the cytoplasm.
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Figure 5. Proper regulation of the pfsr1 gene is essential for parasites’ proliferation in human RBCs. Over-expression of pfsr1 gene inhibits parasite
proliferation. (A) Schematic map of the plasmid (pHBIPfSR1myc) used for ectopically over-expression using increasing concentrations of blasticidin
as described (28). Steady-state mRNA levels of pfsr1 and renilla luciferase genes were measured using qRT–PCR from tightly synchronized parasite
cultures 36-h post-invasion (hpi). Values are presented as relative copy number to the housekeeping genes arginyl-tRNA synthetase (PFL0900c).
(B) Transcription levels of pfsr1 and renilla luciferase expressed from the transfected episomes by parasites growing under 2 and 6 mg/ml blasticidin
selection. (C) Growth curves of the parasite populations over-expressing pfsr1 (light gray) compared with those that similarly express renilla luciferase
(black) from the pHBIPfSR1myc and the pHBIRH plasmids, respectively, under 2 mg/ml blasticidin. Arrows indicate days in which the culture was
cut down to avoid over-parasitemia. Each curve represents the average of three different cultures grown in parallel. (D) Growth curves of the parasite
populations over-expressing pfsr1 (light gray) compared with those that similarly express renilla luciferase (black) from the pHBIPfSR1myc and the
pHBIRH plasmids, respectively, under 6 mg/ml blasticidin. Day 0 represents the day in which blasticidin concentration was increased. Each curve
represents the average of three different parasitemia measurements. (E) Growth curves of the parasite populations over-expressing the different
PfSR1 mutants (gray) compared with those that similarly express renilla luciferase (black) under 2 mg/ml blasticidin.
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parasites transfected with the pHBIRH plasmid that
express renilla luciferase. We have identified AS events in
three different P. falciparum genes that are specifically
associated with over-expression of pfsr1 (Figure 6).
The first example is the influence of PfSR1 on the blood
stage antigen 41–3 precursor (PFL0385c). For this gene,
two mRNA isoforms are detected in NF54 parasites using
primers designed to anneal to the third and the last exons
(Figure 6A). Both mRNA isoforms are also detected
in parasites that were transfected with pHBIRH and
pHBISR1myc growing on low dose of 2 mg/ml blasticidin.
However, when drug pressure was increased to 6 mg/ml
blasticidin, the splicing pattern shifted only in parasite
over-expressing pfsr1 that under these conditions favored
the large (726 bp) isoform over the short (474 bp) isoform
(Figure 6A). This change is specific to the parasite line
that over-expressed pfsr1 on 6 mg/ml blasticidin while the
control parasite populations showed no change in mRNA
splicing. Similarly, over-expression of pfsr1 was associated
with specific changes in mRNA splicing of putative
kinesin (PFA0535c) and PFE0480c (conserved plasmo-
dium protein with unknown function) in parasites
carrying the pHBIRS1myc episome and selected on
6 mg/ml blasticidin (Figure 6B and C, respectively).
Over-expression of PfSR1 caused a clear preference for
the 394-bp mRNA isoform of the putative kinesin
(Figure 6B) and for the 857 - and 322-bp mRNA
isoforms in PFE0480c (Figure 6C). Here as well the
observed effect on AS was specific to the high level of
pfsr1 over-expression. Altogether, these data indicate
that PfSR1 influences AS activity of endogenous P. falcip-
arum genes in vivo.
DISCUSSION
Alternative pre-mRNA splicing is an important mechan-
ism of post-transcriptional regulation of gene expression
in eukaryotes. AS events were reported in Plasmodium
many years ago; however, only recently with the establish-
ment of whole genome approaches that allow genome-
wide transcriptome analyses has it become clear that AS
events are much more abundant in P. falciparum during
the IDC than previously considered (10,11). The genome
of P. falciparum seems to have a relatively low number
of genes. The recent finding of genome-wide abundance
of different mRNA isoforms that are encoded by the same
genes (10,11) might indicate that AS in P. falciparum is an
important mechanism by which the parasite can expand its
proteome out of a limited number of genes to be able to
adapt such a complex life cycle. To our knowledge, our
findings demonstrate PfSR1 (PFE0865c) as the first func-
tional AS factor found in the genome of Plasmodium
or any other apicomplexan parasite. We show that
purified recombinant PfSR1 added in vitro to splicing
deficient HeLA S100 extracts is able to complement
splicing activity similar to the mammalian SR protein
SRSF1 indicating that it is a bona fide SR protein.
Moreover, similar to SRSF1 we demonstrated that
PfSR1 can affect the ss selection of two different
mini-genes in mammalian cells. These results indicate
that PfSR1 is able to cooperatively interact with the mam-
malian splicing machinery to function as an AS factor
resulting in a preference for specific splicing isoforms.
This might imply that the basic components that are
required for alternative pre-mRNA splicing are conserved
even in these evolutionarily distinct eukaryotes. However,
it is clear that PfSR1 confers unique features that are
distinct from other eukaryote SR proteins. A recent
study that identified PfSRPK1 as the kinase that interacts
with PfSR1 and phosphorylates its RS domain also
E3 E8
A PFL0385c
726 bp
474 bp
B
EBA165
E1 E4
PFE0480c
394 bp
293 bp
485 bp
EBA165
C
E1 E6
857 bp
952 bp
PFA0535c
 
EBA165
322 bp
Figure 6. Over-expression of the pfsr1 influences AS activity in
P. falciparum. RT–PCR amplifications on cDNA of three P. falciparum
endogenous genes reveals specific changes in their splicing patterns
mediated by PfSR1. cDNA from NF54, wile-type untrasfected para-
sites was used as control. For each gene RT–PCR amplifications
of mRNA extracted from parasites transfected with either pHBIRH
or pHBISR1myc and selected on 2 and 6 mg/ml blasticidin are
presented. Primers used for these amplifications are listed in
Supplementary Table S1. (A) The spliced isoforms obtained for
PFL0385c. (B) The spliced isoforms obtained for PFE0480c and (C)
The splicing isoforms obtained PFA0535c. Schematic of the genes and
the differentially spliced isoforms is shown on the left. Exons are
illustrated in boxes and introns in lines. Positions of the PCR
primers that were used to amplify each gene are indicated. EBA165
(PFD1155w) was used as loading control and is presented in the
lower panels. All of the detected isoforms were sub-cloned and
sequenced.
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showed that the phospho-epitopes generated by PfSRPK1
on the RS domain are not recognized by mAb104. This
may imply that these phospho-epitopes are different than
those of SRSF1, most likely due to variation in the RS
domains of SRSF1 and PfSR1 (18). Our in silico search for
putative SR proteins in P. falciparum indicated that some
of the predicted proteins possess an unusual RS domain
which is different than other eukaryotes and contain less
Ser/Arg repeats. Whether these are indeed RS domains
will need further functional validation.
The elegant study of Dixit et al. (18) demonstrated that
PfSRPK1’s interaction with PfSR1 influences the ability
of PfSR1 to bind RNA in vitro and showed that these two
proteins colocalize during the IDC, thus supporting the
hypothesis that PfSR1 is indeed an SR protein.
However, while our results support the previous observa-
tion that PfSR1 shuttles between the nucleus and the cyto-
plasm during the IDC, we found some distinct differences
in the patterns of cellular localization of PfSR1 compared
with what was previously reported. First, we found that
the nuclear location of PfSR1 at early ring stages is in a
distinct punctuated pattern mainly at the nuclear periph-
ery and is not equally spread all over the nucleus as pre-
viously shown. The pattern of sub-nuclear localization of
PfSR1 in ring stages shown here is more similar to the
sub-nuclear localization of SRSF1 which is found at
distinct nuclear speckles (37). These speckles are believed
to be sub-nuclear storage compartments for SR proteins
and other splicing factors (12). In addition, while PfSR1 in
the cytoplasm seems to be more evenly spread than in
the nucleus, it is clear that its cytoplasmic location is re-
stricted to region that are outside the food vacuole, while
previously it was shown throughout the entire cytoplasm
(18). These previous data were obtained using poly-
clonal antibodies raised against recombinant PfSR1. It is
possible that IFAs using an epitope tagged PfSR1 have an
advantage in getting better resolution for cellular localiza-
tion as detected here.
Our deletion analyses of the PfSR1 mutants lacking dif-
ferent domains have indicated that the RS domain of
PfSR1 acts as NLS similar to the mammalian SRSF1
(37). Interestingly, deletion of either of the RRM
domains seems to have no effect on the cellular location
of PfSR1. Some of the mammalian SR proteins, including
SRSF1, shuttle continuously between the nucleus and the
cytoplasm (44). This movement was found to be
associated with phosphorylation of specific residues at
the RS or RRM domains. One can hypothesize that phos-
phorylation of the RS domain of PfSR1 by PfSRPK1 in-
fluences it’s binding affinity for mRNA, and that this
modification could also regulate its cellular localization
and function in P. falciparum. The dynamic cellular local-
ization of PfSR1 may reflect a functional transition of
PfSR1 during the IDC, from mainly nuclear functions
such as splicing and AS at early ring stages to additional
roles that take place in cytoplasm in late stages and in
gametocytes. In recent years there is mounting evidence
that SR proteins in metazoans are involved in many other
cellular processes. These include chromatin re-modeling,
transcription, cell cycle progression, mRNA export,
nonsense-mediated mRNA decay (NMD) and translation
(12,13,36,45). One cannot exclude that in addition to its
role in splicing and AS shown here, PfSR1 may have other
functions as indicated by its localization both to the
nucleus and cytoplasm. Ectopic over-expression of pfsr1
caused strong inhibition of culture growth even at rela-
tively low levels of gene over-expression, indicating that
tight regulation of pfsr1 is essential for parasite prolifer-
ation in human RBCs. These results are supported by ex-
periments showing that only low levels (2-fold) of over-
expression of several SR proteins could be achieved in
mammalian cells before they underwent apoptosis (39).
In addition, reduced expression of SRSF1 was found to
elicit genomic instability and apoptosis (46,47). The in-
volvement of SR proteins in several of the basic cellular
processes in living cells can explain why P. falciparum
parasites tightly regulate pfsr1 so that even the low levels
of over-expression obtained here caused significant growth
inhibition. Interestingly, over-expression of the RRM2
and the RS mutants had growth inhibition phenotypes
while the parasites over-expressing RRM1 had normal
growth rate. These results might indicate that the role of
PfSR1 in regulating parasite proliferation in human RBCs
involves primarily RNA targets recognized by RRM1.
Similarly, it has been recently shown that RRM1 of
SRSF1 has an essential role in proliferation of
mammary epithelial cells (42).
It is likely that P. falciparum harbors additional SR
proteins that might be regulated by kinases other than
PfSRPK1. It was recently shown that PfCLKs can phos-
phorylate recombinant PfASF-1 (PF11_0205) in vitro (35).
However, even though this protein has an overall 42%
amino acid identity with SRSF1 it lacks an RS domain.
In addition, other putative SR proteins such as PfSR1 and
PF10_0217 are closer orthologs of SRSF1. What role
PfASF-1 or other putative P. falciparum SR proteins
play in RNA metabolisms in Plasmodium and how they
are regulated by PfCLKs is still an open question.
The identification of PfSR1 as the first functional AS
factor in P. falciparum will hopefully set the platform
toward investigating in depth the role of AS in the
biology of this pathogen. We were able to show that
PfSR1 influences AS activity of three endogenous genes
in vivo including a gene that encodes for an antigen ex-
pressed on the surface of RBCs. Whole genome
approaches are now available that will hopefully soon
enable the identification of additional gene targets that
are alternatively spliced by PfSR1 and thus point toward
potential biological processes that are regulated by PfSR1.
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